World's Best Scientists 2026 revealed!
Steven E. Schild

Steven E. Schild

D-Index & Metrics

Medicine

D-Index
95
Citations
42218
World Ranking
9924
National Ranking
5106

Steven E. Schild publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Steven E. Schild sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 801 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Steven E. Schild D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Steven E. Schild sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Steven E. Schild is a researcher affiliated with the Mayo Clinic in the United States whose work primarily spans the field of Medicine. Their research largely focuses on subfields within pulmonary and respiratory medicine, oncology, radiation, surgery, and radiology, nuclear medicine and imaging.

The scientist has contributed extensively to several main topics of study, which include:

  • Advanced Radiotherapy Techniques
  • Brain Metastases and Treatment
  • Radiation Therapy and Dosimetry
  • Glioma Diagnosis and Treatment
  • Management of metastatic bone disease
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Research Studies

Schild has published numerous papers with notable appearances in various scientific venues. Frequent publication outlets include:

  • Anticancer Research
  • International Journal of Radiation Oncology*Biology*Physics
  • In Vivo
  • Medical Physics
  • Cancers

Collaborations are a significant aspect of Schild's work, involving repeated partnerships with several co-authors, among them:

  • Dirk Rades
  • William W. Wong
  • Nathan Y. Yu
  • Carlos Vargas
  • Sameer R. Keole

Some of the recent papers associated with Steven E. Schild include:

  • Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology (2022), published in the Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021 (2021), published in the Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023 (2023), published in the Journal of the National Comprehensive Cancer Network
  • Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement (2020), published in Radiotherapy and Oncology
  • Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617 (2021), published in Cancers

Best Publications

  • Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

    Julian R. Molina;Ping Yang;Stephen D. Cassivi;Steven E. Schild

  • Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

    Jeffrey D. Bradley;Rebecca Paulus;Ritsuko Komaki;Gregory Masters

  • Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology

    David S. Ettinger;Douglas E. Wood;Dara L. Aisner;Wallace Akerley

  • Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines

    David S. Ettinger;Douglas E. Wood;Charu Aggarwal;Dara L. Aisner

  • NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

    David S. Ettinger;David S. Ettinger;Douglas E. Wood;Douglas E. Wood;Dara L. Aisner;Wallace Akerley;Wallace Akerley

  • Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial

    Stephen G. Chun;Chen Hu;Hak Choy;Ritsuko U. Komaki

  • Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis

    Svetomir N. Markovic;Lori A. Erickson;Ravi D. Rao;Robert R. McWilliams

  • Malignant peripheral nerve sheath tumor: analysis of treatment outcome

    William W. Wong;Takanori Hirose;Bernd W. Scheithauer;Steven E. Schild

  • Non–Small Cell Lung Cancer, Version 6.2015

    David S. Ettinger;Douglas E. Wood;Wallace Akerley;Lyudmila A. Bazhenova

  • NCCN Guidelines ® Insights: Non-Small Cell Lung Cancer, Version 4.2016 Featured Updates to the NCCN Guidelines

    David S. Ettinger;Douglas E. Wood;Wallace Akerley;Lyudmila A. Bazhenova

  • NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018

    David S. Ettinger;Dara L. Aisner;Douglas E. Wood;Wallace Akerley

  • Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Neurocognitive and Quality-of-Life Analysis

    Alexander Sun;Kyounghwa Bae;Elizabeth M. Gore;Benjamin Movsas

  • Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.

    Jeffrey D. Bradley;Chen Hu;Ritsuko R. Komaki;Gregory A. Masters

  • Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

    James R. Jett;Steven E. Schild;Kenneth A. Kesler;Gregory P. Kalemkerian

  • A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)

    Gregory M.M. Videtic;Chen Hu;Anurag K. Singh;Joe Y. Chang

  • Evaluation of Five Radiation Schedules and Prognostic Factors for Metastatic Spinal Cord Compression

    Dirk Rades;Lukas J.A. Stalpers;Theo Veninga;Rainer Schulte

  • Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214

    Elizabeth M. Gore;Kyounghwa Bae;Stuart J. Wong;Alexander Sun

  • Prognostic Factors for Local Control and Survival After Radiotherapy of Metastatic Spinal Cord Compression

    Dirk Rades;Fabian Fehlauer;Rainer Schulte;Theo Veninga

  • The Outcome of Combined-Modality Therapy for Stage III Non-Small-Cell Lung Cancer in the Elderly

    Steven E. Schild;Philip J. Stella;Susan M. Geyer;James A. Bonner

  • Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

    Audrey Mauguen;Cécile Le Péchoux;Michele I. Saunders;Steven E. Schild

Frequent Co-Authors

Alex A. Adjei
Alex A. Adjei Cleveland Clinic
James R. Jett
James R. Jett Mayo Clinic
Peter Hoskin
Peter Hoskin University of Manchester
Everett E. Vokes
Everett E. Vokes University of Chicago
Robert L. Foote
Robert L. Foote Mayo Clinic
Ramaswamy Govindan
Ramaswamy Govindan Washington University in St. Louis
Ritsuko Komaki
Ritsuko Komaki The University of Texas MD Anderson Cancer Center
Joe Y. Chang
Joe Y. Chang The University of Texas MD Anderson Cancer Center
Lucian R. Chirieac
Lucian R. Chirieac Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Medicine but want to explore broader healthcare careers or alternative pathways, there are several related online degrees to consider. For example, advanced nursing roles are in high demand across the United States. Many professionals are now opting for the fastest pmhnp program options, which help registered nurses quickly transition into psychiatric-mental health nurse practitioner roles to address ongoing mental health needs.

Administration and leadership opportunities are also expanding rapidly. For those more interested in the business side of healthcare, pursuing a healthcare administration degree cost analysis can help identify budget-friendly options. If you’re seeking graduate-level leadership roles, several affordable mha online programs are available, providing flexible and cost-effective paths to a Master of Healthcare Administration degree.

For those aiming for top clinical leadership positions, Doctor of Nursing Practice (DNP) degrees are a popular route. Students can find the most affordable dnp programs to advance their qualifications while keeping costs manageable. These online options offer flexible schedules, making them accessible to working professionals and career changers.

Best Scientists Citing Steven E. Schild

Trending Scientists

Recently Published Articles